CHAPTER 1 Biology of genital human papillomaviruses

International Journal of Gynecology and Obstetrics

Volumn 94, Issue SUPPL. 1, 2006, Pages

  Villa, Luisa Lina ^a  

^a NONE

Author keywords

Genetic alterations; HPV genome; Immunity; Transformation

Indexed keywords

GENE PRODUCT; PROTEIN E6; PROTEIN E7;

ARTICLE; BASE PAIRING; DISEASE COURSE; DNA DETERMINATION; DNA VIRUS; FEMALE; GENE; GENE CONTROL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNITY; L1 GENE; L2 GENE; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; UTERINE CERVIX CANCER; VIRUS TYPING; WART VIRUS;

EID: 33846622712     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(07)60003-4     Document Type: Article

References (21)

1. De Villiers E., Fauquet C., Broker T., Bernard H., and zur Hausen H. Classification of papillomaviruses. Virology 324 1 (2004) 17-27
2. Munger K., and Howley P. Human papillomavirus immortalization and transformation functions. Virus Res 89 2 (2002) 213-228
3. Baseman J., and Koutsky L. The epidemiology of human papillomavirus infections. J Clin Virol 32 suppl 1 (2005) S16-S24
4. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184 1 (1991) 9-13
5. Munoz N., Bosch F., de Sanjose S., et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 6 (2003) 518-527
6. International Agency for Research on Cancer. Evaluation of Carcinogenic Risk in Humans: Human Papillomavirus. Lyon, France: IARC; 2006. IARC Monograph. In press.
7. Walboomers J., Jacobs M., Manos M., Bosch X., Kummer J., Shah K., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 1 (1999) 12-19
8. von Knebel, and Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38 17 (2002) 2229-2242
9. Duensing S., and Munger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109 2 (2004) 157-162
10. Steenbergen R., de Wilde J., Wilting S., Brink A., Snijders P., and Meijer C. HPV-mediated transformation of the anogenital tract. J Clin Virol 32 suppl 1 (2005) S25-S33
11. Badal V., Chuang L., Tan E., Badal S., Villa L., Wheeler C., et al. CpG methylation of human papillomavirus type 16 DMA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77 11 (2003) 6227-6234
12. Stanley M. Immune intervention in HPV infections: current progress and future developments. Expert Rev Vaccines 5 (2003) 615-617
13. Konya J., and Dillner J. Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82 (2001) 205-238
14. O'Brien P., and Campo S. Evasion of host immunity direct by papillomavirus-encoded proteins. Virus Res 88 (2002) 103-117
15. Aguilar L., Lazcano-Ponce E., Vaccarella S., Cruz A., Hernandez P., Smith J., et al. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect 82 1 (2006) 31-33
16. Hernandez B., McDuffie K., Goodman M., Wilkens L., Thompson P., Zhu X., et al. Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol 44 2 (2006) 513-517
17. Kjaer S., Munk C., Winther J., Jorgensen H., Meijer C., and van den Brule A. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 14 6 (2005) 1528-1533
18. Castellsague X., and Munoz N. Cofactors in human papillomavirus carcinogenesis: role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31 (2003) 20-28 Chapter 3.
19. Bleeker M., Berkhof J., Hogewoning C., Voorhorst F., van den Brule A., Starink T., et al. HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer 92 8 (2005) 1388-1392
20. Pastrana D., Vass W., Lowy D., and Schiller J. NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16. Virology 279 1 (2001) 361-369
21. Berry J., Palefsky J., and Welton M. Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am 13 2 (2004) 355-373